SCOPUS 정보 검색 플랫폼

Journal of Generic Medicines

Volumn 4, Issue 1, 2006, Pages 43-45

Potential savings from increased substitution of generic for originator medicines in Europe

(1) Simoens, Steven a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; CALCULATION; COST CONTROL; DRUG COST; DRUG MARKETING; DRUG SUBSTITUTION; EUROPE; HEALTH CARE COST; HEALTH CARE POLICY; INTERNATIONAL COOPERATION; METHODOLOGY; PUBLIC HEALTH;

EID: 33846860583 PISSN: 17411343 EISSN: 17417090 Source Type: Journal
DOI: 10.1057/palgrave.jgm.4950040 Document Type: Article

Times cited : (18)

References (9)

1
- 33846884339
- IMS Health IMS Health, London, accessed February 2006
- IMS Health (2004). Midas database. IMS Health, London, accessed February 2006.
- (2004) Midas Database

2
- 33846880007
- Sustaining generic medicines markets in Europe
- Simoens, S. & De Coster, S. (2006). Sustaining generic medicines markets in Europe. J. Generic Med. 3, 257-268.
- (2006) J. Generic Med. , vol.3 , pp. 257-268
- Simoens, S.¹ De Coster, S.²

3
- 20344361935
- Potential savings from substituting generic drugs for brand-name drugs: Medical expenditure panel survey, 1997-2000
- Haas, J.S., Phillips, K.A., Gerstenberger, E.P. & Seger, A.C. (2005). Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann. Int. Med. 142, 891-897.
- (2005) Ann. Int. Med. , vol.142 , pp. 891-897
- Haas, J.S.¹ Phillips, K.A.² Gerstenberger, E.P.³ Seger, A.C.⁴

4
- 33846880834
- Express Scripts, St. Louis. accessed 16th Jan 2006
- Cox, E., Behm, A., Mager, D. & Miller, S. (2004). Generic drug usage report, Express Scripts, St. Louis. www.express-scripts.com, accessed 16th Jan 2006.
- (2004) Generic Drug Usage Report
- Cox, E.¹ Behm, A.² Mager, D.³ Miller, S.⁴

5
- 27844552254
- The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland
- Tilson, L., Bennett, K. & Barry, M. (2005). The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland. Eur. J. Health Econ. 6, 267-273.
- (2005) Eur. J. Health Econ. , vol.6 , pp. 267-273
- Tilson, L.¹ Bennett, K.² Barry, M.³

6
- 0042357382
- Economic consequences of underuse of generic drugs: Evidence from Medicaid and implications for prescription drug benefit plans
- Fischer, M.A. & Avorn, J. (2003). Economic consequences of underuse of generic drugs: Evidence from Medicaid and implications for prescription drug benefit plans. Health Service Res. 38, 1051-1063.
- (2003) Health Service Res. , vol.38 , pp. 1051-1063
- Fischer, M.A.¹ Avorn, J.²

7
- 0029888129
- Potential savings from generic prescribing and generic substitution in South Africa
- Karim, S.S., Pillai, G., Ziqubu-Page, T.T., Cassimjee, M.H. & Morar, M.S. (1996). Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan. 11, 198-205.
- (1996) Health Policy Plan , vol.11 , pp. 198-205
- Karim, S.S.¹ Pillai, G.² Ziqubu-Page, T.T.³ Cassimjee, M.H.⁴ Morar, M.S.⁵

8
- 0036689918
- Encouraging the use of generic medicines: Implications for transition economies
- King, D.R. & Kanavos, P. (2002). Encouraging the use of generic medicines: Implications for transition economies. Croatian Med. J. 43, 462-469.
- (2002) Croatian Med. J. , vol.43 , pp. 462-469
- King, D.R.¹ Kanavos, P.²

9
- 33846884127
- G10 High Level Group on Innovation and Provision of Medicines in the European Union European Commission, London. accessed 14th March 2006
- G10 High Level Group on Innovation and Provision of Medicines in the European Union (2002). Recommendations for action, European Commission, London. http://europa.eu.int, accessed 14th March 2006.
- (2002) Recommendations for Action

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.